Parkinson'
Conditions
Interventions
-
The patients was randomized to gabapentin for 4 weeks
-
The dose of gabapentin depend on body weight,
if BW less than 50 kg titrate dose up to 300 mg/day,
if BW equal or more than 50 mg titrate dose up to 600 mg/day,The patients was randomized to quetiapine for 4 weeks
-
The dose of quetiapine depend on body weight,
if BW less than 50 kg titrate dose up to 50 mg/day,
if BW equal or more than 50 mg titrate dose up to 75 mg/day
Active Comparator Drug,Active Comparator Drug
Gabapentin,Quetiapine
Sponsors
Research and Development Center
Eligibility
Sex/Gender
All
Age
40 Years to 90 Years
Inclusion criteria
Inclusion criteria: PD patients who are being the visual hallucination for at least 1 months duration.
Exclusion criteria
Exclusion criteria: 1. Pateints with communication problem 2. Patients who are taking gabapentin or antipsychotic medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual hallucination 4 weeks after take each medication interview | — |
Secondary
| Measure | Time frame |
|---|---|
| N/A N/A N/A | — |
Countries
Thailand
Contacts
Public ContactChumpol Anamnart
Prapokklao Hospital
Outcome results
None listed